Positron Emission Tomography Facilitates Diagnosis of Early-Onset Alzheimer’s DiseaseMcMurtray A.M.a, b · Licht E.a, b · Yeo T.a · Krisztal E.a · Saul R.E.a, b · Mendez M.F.a, b
aDepartment of Neurology, University of California at Los Angeles (UCLA), and bVA Greater Los Angeles Healthcare System, Los Angeles, Calif., USA Eur Neurol 2008;59:31–37 (DOI:10.1159/000109258)
Background: Clinical positron emission tomography (PET) may help in the evaluation of presenile patients with memory complaints for the presence of Alzheimer’s disease (AD). Methods: Clinical PET scans from 27 patients with clinically probable AD and early ages of onset (<65 years) were compared to PET scans from 27 age-matched controls presenting with memory complaints, but without dementia or mild cognitive impairment. Results: Compared to controls, the AD patients had significant frontal, temporal and parietal hypometabolism bilaterally, and AD diagnosis correlated with left temporal and right temporoparietal hypometabolism. The sensitivity of temporoparietal hypometabolism for AD was 92.6%, the specificity 85.2%. Conclusion: Clinical PET imaging helps distinguish early-onset AD from patients with memory complaints not meeting criteria for dementia or mild cognitive impairment.
|Direct payment||This item at the regular price: USD 38.00|
|Payment from account||With a Karger Pay-per-View account (down payment USD 150)
you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50